Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. - Test2 - elhamkhani - TriplyDB

Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.

Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.

http://www.wikidata.org/entity/Q50797819

about

HMGA1-pseudogenes and cancer Pancreatic cancer: molecular pathogenesis and new therapeutic targets.High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma.Current knowledge on pancreatic cancer.Critical role of HMGA proteins in cancer cell chemoresistance.Apoptotic pathways in pancreatic ductal adenocarcinoma Risk factors and therapeutic targets in pancreatic cancer.HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiency HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines.Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability.Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration.

P2860

Q28072498-71A4297B-97D3-42A4-8DC1-75C0B55066BD Q33899954-E2DC0E9D-C350-4007-AFE5-04C1E6CE600B Q34721443-ADBD56AD-B4B1-4E91-8270-D28BA467197B Q34974696-0107045F-E3ED-4A49-A3EB-6A20CFB4B204 Q35971808-4D9E35A2-6773-4AE8-8D11-11D0FA7E052B Q36308084-C7DBCF14-43D1-42EB-945A-0890D1F64C19 Q36835642-68FAE585-1882-4783-9D2E-6F7904296326 Q37317310-86570D62-0F89-4895-A3A6-C4E3A9897FF4 Q37374734-5DB73F05-755D-4D7A-AA49-B20E3E72E9B0 Q37556169-D05669A4-0EF5-458D-BC25-F8AA4D5D0A67 Q37736030-0500609D-79C5-4451-853B-01CDD6E84779 Q38339945-C32D9405-392D-4149-B554-1EC929617477 Q40162429-C027A413-CA78-4811-884E-113F74E94130 Q51743664-9A28A11D-EA3E-4219-AB76-0DB960F07DDB Q52629180-B7E7F9D3-8AFA-471E-979F-EC82C79CE4FF

P2860

Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.

http://www.wikidata.org/entity/Q50797819

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Therapy of human pancreatic ca ...... nthesis in preclinical models.

@en

Therapy of human pancreatic ca ...... nthesis in preclinical models.

@nl

type

label

Therapy of human pancreatic ca ...... nthesis in preclinical models.

@en

Therapy of human pancreatic ca ...... nthesis in preclinical models.

@nl

prefLabel

Therapy of human pancreatic ca ...... nthesis in preclinical models.

@en

Therapy of human pancreatic ca ...... nthesis in preclinical models.

@nl

P1433

Q50797819-C2DCC3C2-D55A-43E0-A6EE-0860BFB2653A

P1476

Q50797819-9520F337-D601-4041-AE06-CBA27D0E5C39

P2093

Q50797819-09975025-9E42-4769-8730-95C2B072D944

Q50797819-178F91A8-95FB-47A5-85F3-574A81FD96B5

Q50797819-3CC3DFEE-5963-4FA1-A1C1-CA8E2847C22C

Q50797819-44AC5A0D-C91D-4681-8C67-F7D80BD1D747

Q50797819-4AC1A4E0-3E29-4542-AEDD-EE53333863A3

Q50797819-6B6BCE5B-03B5-49C1-A03E-ED0199C374E2

Q50797819-B04FAC9B-4DE4-4DAD-A1CA-17E6D48D1E07

Q50797819-B0DBA316-697F-4D02-B9F4-D210BD532FDB

Q50797819-E5087132-E75F-4517-8521-1ECDB8FAF21B

Q50797819-F8B7C32B-A92F-4645-83A5-8347EA239309

P2860

Q50797819-0862A314-9C2C-4BF8-907F-A5072CA3FEF7

Q50797819-0DDA9F68-48F7-4B0C-89ED-9E611F6B45F1

Q50797819-1B207A65-E079-4283-A590-897F058680F2

Q50797819-1C91550F-BF1B-47D9-ACB6-000883BDE4D6

Q50797819-1E915385-A735-4AE1-B9A8-2E64EA777AF1

Q50797819-52BFC534-B336-454E-BB38-B0439C9DB12C

Q50797819-56981678-C811-4ED8-8BE4-F3ED9ECF1A06

Q50797819-5E9C3B4C-79E4-4DA8-B74A-CA8AC6405573

Q50797819-62DFDF4D-E7A7-4423-A23F-A44D81CC032B

Q50797819-6AB86B7B-5971-47D3-B6FB-C8F5937A43C8

P2888

Q50797819-C4B5D676-194D-468F-AA9B-F5B224930554

P304

Q50797819-BC66661A-75D9-4E9A-9C87-0E097AE95824

P31

Q50797819-8B5BA64E-F0E7-4456-948D-99CC7BD0007C

P356

Q50797819-94FE109B-1825-496F-A8C9-283A78EC4150

P433

Q50797819-0EADC6FF-CA62-4427-B7D1-BFB66B1D47E4

P478

Q50797819-D8351495-EAB4-4E98-8B51-9B86A0684838

P50

Q50797819-98EA5399-D74D-4563-BFDD-071EC752A145

Q50797819-B5B361D0-51FF-4AE8-9BC3-9B5C5DF80AB7

Q50797819-BEE884F2-8EFE-4555-B800-FBA23C9D8EBD

Q50797819-CA03AEF9-8B92-4DAB-A11C-5BA5F5338AAD

P577

Q50797819-AFECBF26-F138-4D11-8465-EA02589B1ED7

P5875

Q50797819-BAEC8148-C26D-41F9-9D34-FFB1A3711768

P698

Q50797819-999299E3-1286-494E-9019-F7CC112B1BAB

P356

P1433

Cancer Gene Therapy

P1476

Therapy of human pancreatic ca ...... nthesis in preclinical models.

@en

P2093

Francesco Trapasso

http://www.w3.org/2001/XMLSchema#string

Giuseppe Viglietto

http://www.w3.org/2001/XMLSchema#string

Hansjuerg Alder

http://www.w3.org/2001/XMLSchema#string

Kristoffel R Dumon

http://www.w3.org/2001/XMLSchema#string

Luisa Infante

http://www.w3.org/2001/XMLSchema#string

Manuela Sarti

http://www.w3.org/2001/XMLSchema#string

Nobutsugu Abe

http://www.w3.org/2001/XMLSchema#string

Rami I Aqeilan

http://www.w3.org/2001/XMLSchema#string

Rossano Cesari

http://www.w3.org/2001/XMLSchema#string

Takashi Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes

Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y

Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

How cells respond to interferons

Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

Pancreatic cancer: a review of emerging therapies.

HMG domain proteins: architectural elements in the assembly of nucleoprotein structures.

Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.

P2888

P304

633-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CGT.7700745

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Pentimalli

Carlo Maria Croce

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8437994

http://www.w3.org/2001/XMLSchema#string

P698

15272314

http://www.w3.org/2001/XMLSchema#string